Cargando…

Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma

BACKGROUND: CNS immune privilege has been challenged in recent years. Glioblastoma (GBM) immune dysfunction includes complex interactions with the immune system outside the CNS. The aim of this study was to determine diagnostic and prognostic potential of immune-related proteins in plasma in GBM and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holst, Camilla Bjørnbak, Christensen, Ib Jarle, Vitting-Seerup, Kristoffer, Skjøth-Rasmussen, Jane, Hamerlik, Petra, Poulsen, Hans Skovgaard, Johansen, Julia Sidenius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284624/ https://www.ncbi.nlm.nih.gov/pubmed/34286278 http://dx.doi.org/10.1093/noajnl/vdab072

Ejemplares similares

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2021)

The HOPX and BLBP landscape and gliogenic regions in developing human brain
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2023)

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM2B
por: Staberg, Mikkel, et al.
Publicado: (2018)

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
por: Urup, Thomas, et al.
Publicado: (2017)

Most protein domains exist as variants with distinct functions across cells, tissues and diseases
por: Vitting-Seerup, Kristoffer
Publicado: (2023)

Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
por: Schou Nørøxe, Dorte, et al.
Publicado: (2021)

Replication Protein A (RPA) Mediates Radio-Resistance of Glioblastoma Cancer Stem-Like Cells
por: Pedersen, Henriette, et al.
Publicado: (2020)

Cell-free DNA in newly diagnosed patients with glioblastoma – a clinical prospective feasibility study
por: Nørøxe, Dorte Schou, et al.
Publicado: (2019)

VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
por: Michaelsen, Signe R, et al.
Publicado: (2018)

SPT6-driven error-free DNA repair safeguards genomic stability of glioblastoma cancer stem-like cells
por: Obara, Elisabeth Anne Adanma, et al.
Publicado: (2020)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
por: Poulsen, Sidsel Højklint, et al.
Publicado: (2016)

Clinical variables serve as prognostic factors in a model for survival from glioblastoma multiforme: an observational study of a cohort of consecutive non-selected patients from a single institution
por: Michaelsen, Signe Regner, et al.
Publicado: (2013)

Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy
por: Bogetofte Barnkob, Mike, et al.
Publicado: (2022)

Expression and splicing mediate distinct biological signals
por: Dam, Søren Helweg, et al.
Publicado: (2023)

spliceR: an R package for classification of alternative splicing and prediction of coding potential from RNA-seq data
por: Vitting-Seerup, Kristoffer, et al.
Publicado: (2014)

A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
por: Abedi, Armita Armina, et al.
Publicado: (2021)

Combined EGFR- and notch inhibition display additive inhibitory effect on glioblastoma cell viability and glioblastoma-induced endothelial cell sprouting in vitro
por: Staberg, Mikkel, et al.
Publicado: (2016)

CAGEfightR: analysis of 5′-end data using R/Bioconductor
por: Thodberg, Malte, et al.
Publicado: (2019)

satuRn: Scalable analysis of differential transcript usage for bulk and single-cell RNA-sequencing applications
por: Gilis, Jeroen, et al.
Publicado: (2022)

Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study
por: Nørøxe, Dorte S., et al.
Publicado: (2020)

Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
por: Urup, Thomas, et al.
Publicado: (2020)

ICOS/ICOSLG and PD-1 Co-Expression is Associated with the Progression of Colorectal Precancerous- Carcinoma Immune Microenvironment
por: Zhang, Yu, et al.
Publicado: (2023)

ICOSLG-associated immunological landscape and diagnostic value in oral squamous cell carcinoma: a prospective cohort study
por: Dong, Yuexin, et al.
Publicado: (2023)

UPF2-Dependent Nonsense-Mediated mRNA Decay Pathway Is Essential for Spermatogenesis by Selectively Eliminating Longer 3'UTR Transcripts
por: Bao, Jianqiang, et al.
Publicado: (2016)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia
por: Külp, Marius, et al.
Publicado: (2022)

Early Detection and Recurrence of Colorectal Adenomas by Combination of Eight Cancer-Associated Biomarkers in Plasma
por: Rasmussen, Louise, et al.
Publicado: (2020)

BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
por: Rasmussen, Rikke D., et al.
Publicado: (2016)

Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
por: Rasmussen, Rikke D., et al.
Publicado: (2018)

The combination of novel immune checkpoints HHLA2 and ICOSLG: A new system to predict survival and immune features in esophageal squamous cell carcinoma
por: Zhang, Chaoqi, et al.
Publicado: (2020)

Presentation of Two Cases with Early Extracranial Metastases from Glioblastoma and Review of the Literature
por: Johansen, Maria Dinche, et al.
Publicado: (2016)

Amplification of pico-scale DNA mediated by bacterial carrier DNA for small-cell-number transcription factor ChIP-seq
por: Jakobsen, Janus S, et al.
Publicado: (2015)

Hallmarks of glioblastoma: a systematic review
por: Nørøxe, Dorte Schou, et al.
Publicado: (2017)

Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017)

Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis
por: Dolin, Troels Gammeltoft, et al.
Publicado: (2021)

Progression of the pluripotent epiblast depends upon the NMD factor UPF2
por: Chousal, Jennifer N., et al.
Publicado: (2022)

A Functional Link between Nuclear RNA Decay and Transcriptional Control Mediated by the Polycomb Repressive Complex 2
por: Garland, William, et al.
Publicado: (2019)

VEGF-C as a putative therapeutic target in cancer
por: Michaelsen, Signe R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hqe23iq51sv2526sq2k3kclva2